

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.82761614 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.15968695 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.62858448 |
| 4 | vocalization behavior (GO:0071625) | 5.59461261 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.47679236 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41473111 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.37867040 |
| 8 | nucleobase catabolic process (GO:0046113) | 5.33458080 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.32912242 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.16916739 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 5.04374118 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.04091459 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.90162576 |
| 14 | protein localization to synapse (GO:0035418) | 4.86306826 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.74345559 |
| 16 | glutamate secretion (GO:0014047) | 4.71219858 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 4.57058325 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.55887520 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.55177430 |
| 20 | exploration behavior (GO:0035640) | 4.50133942 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.37865828 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.35989188 |
| 23 | establishment of mitochondrion localization (GO:0051654) | 4.31764325 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.22364841 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.20395546 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.15501155 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.15047474 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.14013431 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 4.12349328 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 4.09578013 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.09468743 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.03166323 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.02807461 |
| 34 | neuron recognition (GO:0008038) | 4.02806319 |
| 35 | proline transport (GO:0015824) | 4.01484632 |
| 36 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.92096709 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.88017743 |
| 38 | retinal ganglion cell axon guidance (GO:0031290) | 3.81850197 |
| 39 | long-term memory (GO:0007616) | 3.79062414 |
| 40 | axonal fasciculation (GO:0007413) | 3.77425207 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76192482 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.74023893 |
| 43 | neurotransmitter transport (GO:0006836) | 3.73573953 |
| 44 | postsynaptic membrane organization (GO:0001941) | 3.63339650 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.62630601 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.60796488 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.60485467 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.52053831 |
| 49 | activation of protein kinase A activity (GO:0034199) | 3.51046728 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.46302282 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.44440052 |
| 52 | cell migration in hindbrain (GO:0021535) | 3.43591075 |
| 53 | regulation of neurotransmitter levels (GO:0001505) | 3.42926942 |
| 54 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.41831223 |
| 55 | prepulse inhibition (GO:0060134) | 3.41521439 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.41107192 |
| 57 | dendrite morphogenesis (GO:0048813) | 3.40985022 |
| 58 | auditory behavior (GO:0031223) | 3.40452943 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38926000 |
| 60 | positive regulation of mitochondrial fission (GO:0090141) | 3.35203630 |
| 61 | neuromuscular process controlling balance (GO:0050885) | 3.34573948 |
| 62 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.33632786 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.32419337 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.32183956 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 3.31844317 |
| 66 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.29866659 |
| 67 | neuromuscular process controlling posture (GO:0050884) | 3.29624702 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 3.29257899 |
| 69 | response to pheromone (GO:0019236) | 3.28549492 |
| 70 | presynaptic membrane assembly (GO:0097105) | 3.27122246 |
| 71 | synapse assembly (GO:0007416) | 3.23302878 |
| 72 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.22844866 |
| 73 | response to auditory stimulus (GO:0010996) | 3.22770347 |
| 74 | response to histamine (GO:0034776) | 3.22742661 |
| 75 | membrane depolarization during action potential (GO:0086010) | 3.22654936 |
| 76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22341451 |
| 77 | membrane hyperpolarization (GO:0060081) | 3.22064084 |
| 78 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.21710808 |
| 79 | mitochondrion transport along microtubule (GO:0047497) | 3.21710808 |
| 80 | neuronal ion channel clustering (GO:0045161) | 3.20589979 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.19939019 |
| 82 | C4-dicarboxylate transport (GO:0015740) | 3.18435205 |
| 83 | long-term synaptic potentiation (GO:0060291) | 3.17626348 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.17376931 |
| 85 | vesicle transport along microtubule (GO:0047496) | 3.17159890 |
| 86 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.16678279 |
| 87 | behavioral fear response (GO:0001662) | 3.15269635 |
| 88 | behavioral defense response (GO:0002209) | 3.15269635 |
| 89 | membrane depolarization (GO:0051899) | 3.12480510 |
| 90 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.11501618 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 3.10862194 |
| 92 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.10295007 |
| 93 | presynaptic membrane organization (GO:0097090) | 3.09607869 |
| 94 | sodium ion export (GO:0071436) | 3.09218639 |
| 95 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.07425621 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07398797 |
| 97 | cell communication by electrical coupling (GO:0010644) | 3.07190115 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05661818 |
| 99 | intraspecies interaction between organisms (GO:0051703) | 3.03949079 |
| 100 | social behavior (GO:0035176) | 3.03949079 |
| 101 | learning (GO:0007612) | 3.03775143 |
| 102 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.03580931 |
| 103 | mating behavior (GO:0007617) | 3.02716823 |
| 104 | protein localization to cilium (GO:0061512) | 3.02215773 |
| 105 | nonmotile primary cilium assembly (GO:0035058) | 3.01358285 |
| 106 | positive regulation of synapse assembly (GO:0051965) | 3.00681577 |
| 107 | synapse organization (GO:0050808) | 2.99908854 |
| 108 | glycine transport (GO:0015816) | 2.97623436 |
| 109 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97521469 |
| 110 | regulation of glutamate secretion (GO:0014048) | 2.96999210 |
| 111 | synaptic transmission (GO:0007268) | 2.96545852 |
| 112 | behavioral response to nicotine (GO:0035095) | 2.96460489 |
| 113 | dopamine receptor signaling pathway (GO:0007212) | 2.96368366 |
| 114 | innervation (GO:0060384) | 2.95867822 |
| 115 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.94929511 |
| 116 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.89529872 |
| 117 | head development (GO:0060322) | 2.89153575 |
| 118 | mechanosensory behavior (GO:0007638) | 2.84483067 |
| 119 | spinal cord development (GO:0021510) | 2.83525804 |
| 120 | olfactory bulb development (GO:0021772) | 2.81606033 |
| 121 | hippocampus development (GO:0021766) | 2.81099929 |
| 122 | limb bud formation (GO:0060174) | 2.79301881 |
| 123 | behavioral response to ethanol (GO:0048149) | 2.73526978 |
| 124 | regulation of synapse assembly (GO:0051963) | 2.68891872 |
| 125 | axon extension (GO:0048675) | 2.67478145 |
| 126 | somite development (GO:0061053) | 2.66813430 |
| 127 | neuromuscular synaptic transmission (GO:0007274) | 2.64526318 |
| 128 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.63159318 |
| 129 | short-term memory (GO:0007614) | 2.62660817 |
| 130 | regulation of development, heterochronic (GO:0040034) | 2.56048929 |
| 131 | central nervous system neuron axonogenesis (GO:0021955) | 2.55887402 |
| 132 | regulation of feeding behavior (GO:0060259) | 2.54766729 |
| 133 | dendritic spine organization (GO:0097061) | 2.53911042 |
| 134 | protein polyglutamylation (GO:0018095) | 2.53240913 |
| 135 | regulation of respiratory system process (GO:0044065) | 2.50145615 |
| 136 | glycosphingolipid biosynthetic process (GO:0006688) | 2.50061067 |
| 137 | * homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.49063952 |
| 138 | axon extension involved in axon guidance (GO:0048846) | 2.48679114 |
| 139 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.48679114 |
| 140 | startle response (GO:0001964) | 2.45472277 |
| 141 | appendage development (GO:0048736) | 2.45365606 |
| 142 | limb development (GO:0060173) | 2.45365606 |
| 143 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.43117091 |
| 144 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.43117091 |
| 145 | intraciliary transport (GO:0042073) | 2.42750747 |
| 146 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.37728647 |
| 147 | adult walking behavior (GO:0007628) | 2.35450112 |
| 148 | axonogenesis (GO:0007409) | 2.33528650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.40685126 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56800770 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14881338 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11049821 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04551456 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84712970 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71308840 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71308840 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70210650 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.68080592 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59915689 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.57876793 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54460311 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.54270579 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.54201902 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.49966181 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49842757 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45800333 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45232834 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44015445 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37457598 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33211936 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27827875 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25067593 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23854882 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18508663 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.15277740 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12940783 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01357865 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95041700 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87617818 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80679039 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79552848 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73288335 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72654044 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65480219 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63826170 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62570483 |
| 39 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.61929576 |
| 40 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60208629 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50117549 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49381425 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47306245 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46572764 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46268452 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43452752 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42629021 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40048582 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39795408 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38291678 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37784462 |
| 52 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.37139345 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37061528 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35911899 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34752498 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34413793 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34253370 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31877807 |
| 59 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.31068993 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29834072 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26905499 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26829703 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24476176 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23688988 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.22255190 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21226509 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19425191 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18303885 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18172765 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17902903 |
| 71 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.17198749 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15422319 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15415262 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15415262 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15135248 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14572108 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14508235 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14278451 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13262228 |
| 80 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.12506483 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08631956 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07757461 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07755941 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07553590 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07030941 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06372787 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06290120 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05392411 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05348439 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04820533 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04800964 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03091420 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02783866 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01963745 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01674096 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00234757 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99406128 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98602196 |
| 99 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97839745 |
| 100 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97793416 |
| 101 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.96910555 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96395548 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96385299 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94819194 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94740514 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94719761 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94228661 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93938248 |
| 109 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93184822 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93057129 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92690718 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92679412 |
| 113 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92473879 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92074645 |
| 115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91961123 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91521828 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91156535 |
| 118 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91050111 |
| 119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90589760 |
| 120 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90199917 |
| 121 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89913253 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89847251 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 0.89648968 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88967090 |
| 125 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.88893141 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88652806 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88504060 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88504060 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86301570 |
| 130 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86035101 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85170603 |
| 132 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82700438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.84840533 |
| 2 | MP0003880_abnormal_central_pattern | 4.86220566 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99321878 |
| 4 | MP0004270_analgesia | 3.38293286 |
| 5 | MP0009745_abnormal_behavioral_response | 3.31407395 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.19523369 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.12206656 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.10507015 |
| 9 | MP0002064_seizures | 3.05592341 |
| 10 | MP0009046_muscle_twitch | 3.04242796 |
| 11 | MP0002822_catalepsy | 2.86170265 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.70863964 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.62755197 |
| 14 | MP0002272_abnormal_nervous_system | 2.46288567 |
| 15 | MP0001486_abnormal_startle_reflex | 2.41806301 |
| 16 | MP0003122_maternal_imprinting | 2.37713369 |
| 17 | MP0002736_abnormal_nociception_after | 2.34466794 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.27867082 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.15410314 |
| 20 | MP0002102_abnormal_ear_morphology | 2.13437105 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.11967146 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.11093122 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.09650344 |
| 24 | MP0003787_abnormal_imprinting | 2.03583990 |
| 25 | MP0000778_abnormal_nervous_system | 2.00448972 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.96136502 |
| 27 | MP0001970_abnormal_pain_threshold | 1.95893707 |
| 28 | MP0002184_abnormal_innervation | 1.95817052 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.87225135 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.81551493 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.75942254 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.75438679 |
| 33 | MP0004924_abnormal_behavior | 1.75438679 |
| 34 | MP0000049_abnormal_middle_ear | 1.72438733 |
| 35 | MP0008789_abnormal_olfactory_epithelium | 1.72180078 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.69765545 |
| 37 | MP0004858_abnormal_nervous_system | 1.66667034 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.66249829 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.66110564 |
| 40 | MP0001529_abnormal_vocalization | 1.61264098 |
| 41 | MP0008569_lethality_at_weaning | 1.60595106 |
| 42 | MP0000955_abnormal_spinal_cord | 1.60202375 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.55740694 |
| 44 | MP0004133_heterotaxia | 1.50147500 |
| 45 | MP0001984_abnormal_olfaction | 1.49631063 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.44058129 |
| 47 | MP0005253_abnormal_eye_physiology | 1.43594455 |
| 48 | MP0003329_amyloid_beta_deposits | 1.43486603 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.39019474 |
| 50 | MP0000566_synostosis | 1.35131831 |
| 51 | MP0004885_abnormal_endolymph | 1.33483028 |
| 52 | MP0004142_abnormal_muscle_tone | 1.32426405 |
| 53 | MP0003119_abnormal_digestive_system | 1.31713149 |
| 54 | MP0003136_yellow_coat_color | 1.30911721 |
| 55 | MP0003121_genomic_imprinting | 1.28111040 |
| 56 | MP0001293_anophthalmia | 1.25832733 |
| 57 | MP0003879_abnormal_hair_cell | 1.24501246 |
| 58 | MP0003011_delayed_dark_adaptation | 1.23714032 |
| 59 | MP0001905_abnormal_dopamine_level | 1.23071891 |
| 60 | MP0003123_paternal_imprinting | 1.22812206 |
| 61 | MP0003938_abnormal_ear_development | 1.21947103 |
| 62 | MP0002152_abnormal_brain_morphology | 1.21034122 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.18579137 |
| 64 | MP0002938_white_spotting | 1.17693223 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.17124952 |
| 66 | MP0003633_abnormal_nervous_system | 1.14783346 |
| 67 | MP0000751_myopathy | 1.13694132 |
| 68 | MP0002233_abnormal_nose_morphology | 1.13221522 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.11593081 |
| 70 | MP0001188_hyperpigmentation | 1.11410801 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10884806 |
| 72 | MP0010030_abnormal_orbit_morphology | 1.10083940 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 1.09315892 |
| 74 | MP0003283_abnormal_digestive_organ | 1.08781486 |
| 75 | MP0003385_abnormal_body_wall | 1.06572170 |
| 76 | MP0000026_abnormal_inner_ear | 1.05487326 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.01478465 |
| 78 | MP0003631_nervous_system_phenotype | 1.00034092 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.99706687 |
| 80 | MP0005391_vision/eye_phenotype | 0.98516713 |
| 81 | MP0005394_taste/olfaction_phenotype | 0.97786565 |
| 82 | MP0005499_abnormal_olfactory_system | 0.97786565 |
| 83 | MP0003755_abnormal_palate_morphology | 0.94774774 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.92894515 |
| 85 | MP0003942_abnormal_urinary_system | 0.91453884 |
| 86 | MP0008872_abnormal_physiological_respon | 0.90825016 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.90758448 |
| 88 | MP0005195_abnormal_posterior_eye | 0.90713620 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.90272710 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.90063060 |
| 91 | MP0002229_neurodegeneration | 0.88531371 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.88128599 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.87575389 |
| 94 | MP0004085_abnormal_heartbeat | 0.87342381 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.87264823 |
| 96 | MP0001177_atelectasis | 0.86447976 |
| 97 | MP0001286_abnormal_eye_development | 0.85943802 |
| 98 | MP0002697_abnormal_eye_size | 0.85203275 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.84833979 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.84169091 |
| 101 | MP0004742_abnormal_vestibular_system | 0.84168354 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.83706785 |
| 103 | MP0005171_absent_coat_pigmentation | 0.78723389 |
| 104 | MP0003861_abnormal_nervous_system | 0.77263487 |
| 105 | MP0003634_abnormal_glial_cell | 0.77150646 |
| 106 | MP0002081_perinatal_lethality | 0.76554473 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.74741512 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.74572066 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.74058838 |
| 110 | MP0003632_abnormal_nervous_system | 0.74023987 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.73228271 |
| 112 | MP0002116_abnormal_craniofacial_bone | 0.72410428 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.72040304 |
| 114 | MP0008874_decreased_physiological_sensi | 0.69798962 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.68609602 |
| 116 | MP0004233_abnormal_muscle_weight | 0.67347679 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.66268344 |
| 118 | MP0003690_abnormal_glial_cell | 0.65346269 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.65264246 |
| 120 | MP0001943_abnormal_respiration | 0.64509709 |
| 121 | MP0005535_abnormal_body_temperature | 0.64378392 |
| 122 | MP0008961_abnormal_basal_metabolism | 0.64131039 |
| 123 | MP0006292_abnormal_olfactory_placode | 0.63966836 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.62827578 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.62217739 |
| 126 | MP0005187_abnormal_penis_morphology | 0.61984741 |
| 127 | MP0002082_postnatal_lethality | 0.59469220 |
| 128 | MP0010770_preweaning_lethality | 0.59469220 |
| 129 | MP0010769_abnormal_survival | 0.58952009 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.58074715 |
| 131 | MP0001664_abnormal_digestion | 0.57999381 |
| 132 | MP0002090_abnormal_vision | 0.57613681 |
| 133 | MP0010768_mortality/aging | 0.55493083 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.54788886 |
| 135 | MP0008877_abnormal_DNA_methylation | 0.53958858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.01867339 |
| 2 | Myokymia (HP:0002411) | 6.38641811 |
| 3 | Focal seizures (HP:0007359) | 5.46330446 |
| 4 | Visual hallucinations (HP:0002367) | 4.75936201 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.33917393 |
| 6 | Atonic seizures (HP:0010819) | 4.33665683 |
| 7 | Febrile seizures (HP:0002373) | 4.17488762 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.12866440 |
| 9 | Absence seizures (HP:0002121) | 3.90467766 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.59989322 |
| 11 | Dialeptic seizures (HP:0011146) | 3.55471781 |
| 12 | Ankle clonus (HP:0011448) | 3.47631542 |
| 13 | Action tremor (HP:0002345) | 3.42166976 |
| 14 | Broad-based gait (HP:0002136) | 3.38313830 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.33677919 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.29685356 |
| 17 | Lissencephaly (HP:0001339) | 3.14271656 |
| 18 | Mutism (HP:0002300) | 3.05648137 |
| 19 | Retinal dysplasia (HP:0007973) | 3.01607481 |
| 20 | Poor eye contact (HP:0000817) | 3.01301569 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.01111574 |
| 22 | Depression (HP:0000716) | 3.00697333 |
| 23 | Medial flaring of the eyebrow (HP:0010747) | 3.00137677 |
| 24 | Nephrogenic diabetes insipidus (HP:0009806) | 2.99394883 |
| 25 | Congenital primary aphakia (HP:0007707) | 2.97366114 |
| 26 | Abnormal eating behavior (HP:0100738) | 2.97003335 |
| 27 | Dysdiadochokinesis (HP:0002075) | 2.94704546 |
| 28 | Hyperventilation (HP:0002883) | 2.93330483 |
| 29 | Truncal ataxia (HP:0002078) | 2.91920548 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.88974854 |
| 31 | Anxiety (HP:0000739) | 2.87110416 |
| 32 | Drooling (HP:0002307) | 2.86246508 |
| 33 | Excessive salivation (HP:0003781) | 2.86246508 |
| 34 | Vaginal atresia (HP:0000148) | 2.85692607 |
| 35 | Genital tract atresia (HP:0001827) | 2.83170775 |
| 36 | Amblyopia (HP:0000646) | 2.78611258 |
| 37 | Limb dystonia (HP:0002451) | 2.77060318 |
| 38 | Progressive inability to walk (HP:0002505) | 2.77032590 |
| 39 | Impaired social interactions (HP:0000735) | 2.74124170 |
| 40 | Abnormal social behavior (HP:0012433) | 2.74124170 |
| 41 | Abnormality of the lower motor neuron (HP:0002366) | 2.70587079 |
| 42 | Cortical dysplasia (HP:0002539) | 2.67662136 |
| 43 | Urinary urgency (HP:0000012) | 2.67593916 |
| 44 | Type II lissencephaly (HP:0007260) | 2.67498593 |
| 45 | Hemiparesis (HP:0001269) | 2.66164258 |
| 46 | Postural instability (HP:0002172) | 2.64435485 |
| 47 | Polyphagia (HP:0002591) | 2.64048925 |
| 48 | Dysmetria (HP:0001310) | 2.63807136 |
| 49 | Spastic gait (HP:0002064) | 2.57770231 |
| 50 | Genetic anticipation (HP:0003743) | 2.57421554 |
| 51 | Termporal pattern (HP:0011008) | 2.53661965 |
| 52 | Insidious onset (HP:0003587) | 2.53661965 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.48302235 |
| 54 | Pachygyria (HP:0001302) | 2.47197618 |
| 55 | Papilledema (HP:0001085) | 2.42981688 |
| 56 | Torticollis (HP:0000473) | 2.42810438 |
| 57 | True hermaphroditism (HP:0010459) | 2.41523058 |
| 58 | Pancreatic cysts (HP:0001737) | 2.40940873 |
| 59 | Impaired smooth pursuit (HP:0007772) | 2.40039522 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.37310560 |
| 61 | Pheochromocytoma (HP:0002666) | 2.36584122 |
| 62 | Scanning speech (HP:0002168) | 2.33032788 |
| 63 | Bradykinesia (HP:0002067) | 2.31184719 |
| 64 | Hemiplegia (HP:0002301) | 2.28553045 |
| 65 | Epileptiform EEG discharges (HP:0011182) | 2.27756180 |
| 66 | Agitation (HP:0000713) | 2.26370094 |
| 67 | Focal dystonia (HP:0004373) | 2.26273741 |
| 68 | Occipital encephalocele (HP:0002085) | 2.25570277 |
| 69 | Nephronophthisis (HP:0000090) | 2.23468735 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.23323468 |
| 71 | Diplopia (HP:0000651) | 2.23323468 |
| 72 | Cutaneous finger syndactyly (HP:0010554) | 2.22581871 |
| 73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22090851 |
| 74 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21022821 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.20491855 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.19005651 |
| 77 | Hepatoblastoma (HP:0002884) | 2.16629126 |
| 78 | Fetal akinesia sequence (HP:0001989) | 2.15680231 |
| 79 | Split foot (HP:0001839) | 2.15331824 |
| 80 | Short 4th metacarpal (HP:0010044) | 2.15312780 |
| 81 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.15312780 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14831080 |
| 83 | Colon cancer (HP:0003003) | 2.14574092 |
| 84 | Stereotypic behavior (HP:0000733) | 2.14530329 |
| 85 | Optic nerve hypoplasia (HP:0000609) | 2.14203307 |
| 86 | Hypsarrhythmia (HP:0002521) | 2.14066754 |
| 87 | Broad alveolar ridges (HP:0000187) | 2.13085384 |
| 88 | Poor coordination (HP:0002370) | 2.11792027 |
| 89 | Absent speech (HP:0001344) | 2.11535777 |
| 90 | Insomnia (HP:0100785) | 2.10147778 |
| 91 | Neuroendocrine neoplasm (HP:0100634) | 2.08751760 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.06196522 |
| 93 | Craniofacial dystonia (HP:0012179) | 2.04442509 |
| 94 | Pointed chin (HP:0000307) | 2.04111779 |
| 95 | Septo-optic dysplasia (HP:0100842) | 2.03755772 |
| 96 | Impaired vibratory sensation (HP:0002495) | 2.02732070 |
| 97 | Renal hypoplasia (HP:0000089) | 2.02385826 |
| 98 | Postaxial hand polydactyly (HP:0001162) | 1.98799111 |
| 99 | Cerebellar dysplasia (HP:0007033) | 1.98752382 |
| 100 | Intention tremor (HP:0002080) | 1.98715852 |
| 101 | Oligodactyly (hands) (HP:0001180) | 1.98523780 |
| 102 | Specific learning disability (HP:0001328) | 1.98437846 |
| 103 | Anophthalmia (HP:0000528) | 1.98398199 |
| 104 | Cutaneous syndactyly (HP:0012725) | 1.97896725 |
| 105 | Hypoventilation (HP:0002791) | 1.97633020 |
| 106 | Vitreoretinal degeneration (HP:0000655) | 1.97032055 |
| 107 | Megalencephaly (HP:0001355) | 1.96929022 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.96687403 |
| 109 | Ventricular fibrillation (HP:0001663) | 1.96345649 |
| 110 | Spastic tetraplegia (HP:0002510) | 1.96171449 |
| 111 | Inability to walk (HP:0002540) | 1.94523744 |
| 112 | Broad foot (HP:0001769) | 1.94182374 |
| 113 | Abnormality of the 4th metacarpal (HP:0010012) | 1.93262806 |
| 114 | Dysmetric saccades (HP:0000641) | 1.93122342 |
| 115 | Incomplete penetrance (HP:0003829) | 1.92707883 |
| 116 | Morphological abnormality of the middle ear (HP:0008609) | 1.92334784 |
| 117 | Gait imbalance (HP:0002141) | 1.91589221 |
| 118 | Esotropia (HP:0000565) | 1.91278377 |
| 119 | Abnormality of midbrain morphology (HP:0002418) | 1.91210760 |
| 120 | Molar tooth sign on MRI (HP:0002419) | 1.91210760 |
| 121 | Hypoplasia of the brainstem (HP:0002365) | 1.91120029 |
| 122 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91120029 |
| 123 | Anterior segment dysgenesis (HP:0007700) | 1.90975132 |
| 124 | Status epilepticus (HP:0002133) | 1.90893327 |
| 125 | Hypoplastic pelvis (HP:0008839) | 1.89502667 |
| 126 | Intestinal atresia (HP:0011100) | 1.88620758 |
| 127 | Narrow forehead (HP:0000341) | 1.88572162 |
| 128 | Abnormality of salivation (HP:0100755) | 1.86486358 |
| 129 | Short foot (HP:0001773) | 1.86074758 |
| 130 | Protruding tongue (HP:0010808) | 1.85080740 |
| 131 | Abnormality of the labia minora (HP:0012880) | 1.83551397 |
| 132 | Generalized myoclonic seizures (HP:0002123) | 1.80930844 |
| 133 | Micropenis (HP:0000054) | 1.80715985 |
| 134 | Psychosis (HP:0000709) | 1.80302456 |
| 135 | Neuronal loss in central nervous system (HP:0002529) | 1.79013454 |
| 136 | Inappropriate behavior (HP:0000719) | 1.78879770 |
| 137 | Hypoplasia of the corpus callosum (HP:0002079) | 1.78760458 |
| 138 | Clonus (HP:0002169) | 1.78417329 |
| 139 | Decreased testicular size (HP:0008734) | 1.77656059 |
| 140 | Abnormal EKG (HP:0003115) | 1.77043736 |
| 141 | Neoplasm of the heart (HP:0100544) | 1.76849383 |
| 142 | Resting tremor (HP:0002322) | 1.76655242 |
| 143 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76654094 |
| 144 | Humeroradial synostosis (HP:0003041) | 1.75879485 |
| 145 | Synostosis involving the elbow (HP:0003938) | 1.75879485 |
| 146 | Annular pancreas (HP:0001734) | 1.75023907 |
| 147 | Gait ataxia (HP:0002066) | 1.74967717 |
| 148 | Sleep apnea (HP:0010535) | 1.74279922 |
| 149 | Hyperthyroidism (HP:0000836) | 1.73500927 |
| 150 | Blue irides (HP:0000635) | 1.72956669 |
| 151 | Bifid tongue (HP:0010297) | 1.72173461 |
| 152 | Postaxial foot polydactyly (HP:0001830) | 1.71577045 |
| 153 | Hyperglycinemia (HP:0002154) | 1.71474214 |
| 154 | Anencephaly (HP:0002323) | 1.69326353 |
| 155 | Oligodactyly (HP:0012165) | 1.67455347 |
| 156 | Short tibia (HP:0005736) | 1.67014026 |
| 157 | Cystic liver disease (HP:0006706) | 1.66838599 |
| 158 | Abnormality of the renal medulla (HP:0100957) | 1.65514690 |
| 159 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.65338471 |
| 160 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.65036317 |
| 161 | Rimmed vacuoles (HP:0003805) | 1.64149211 |
| 162 | Polymicrogyria (HP:0002126) | 1.63010796 |
| 163 | Fibular aplasia (HP:0002990) | 1.61324052 |
| 164 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.61171117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.71920045 |
| 2 | MARK1 | 4.02158916 |
| 3 | MAP3K9 | 3.82610421 |
| 4 | EPHA4 | 3.69127200 |
| 5 | MAP3K4 | 3.19214825 |
| 6 | MINK1 | 2.76260186 |
| 7 | MAP2K7 | 2.60834438 |
| 8 | NTRK2 | 2.59462469 |
| 9 | MAP4K2 | 2.49937547 |
| 10 | CASK | 2.25029217 |
| 11 | TRIM28 | 2.22282879 |
| 12 | MAP3K12 | 2.19716360 |
| 13 | DAPK2 | 2.10063797 |
| 14 | PAK6 | 2.04675107 |
| 15 | TNIK | 2.04153618 |
| 16 | MAP2K4 | 1.92256131 |
| 17 | KSR2 | 1.90127328 |
| 18 | PNCK | 1.78259493 |
| 19 | MAPK13 | 1.75638981 |
| 20 | KSR1 | 1.70401789 |
| 21 | NTRK1 | 1.66972700 |
| 22 | SRPK1 | 1.64893725 |
| 23 | PRKD3 | 1.61297342 |
| 24 | CAMKK1 | 1.49930462 |
| 25 | CDK5 | 1.49546433 |
| 26 | CSNK1A1L | 1.44951790 |
| 27 | SIK2 | 1.42164803 |
| 28 | PLK2 | 1.41745613 |
| 29 | EPHA3 | 1.32083651 |
| 30 | GRK5 | 1.32047058 |
| 31 | DAPK1 | 1.31889302 |
| 32 | UHMK1 | 1.30925737 |
| 33 | CSNK1G1 | 1.29092466 |
| 34 | DYRK3 | 1.24156994 |
| 35 | LATS2 | 1.23083224 |
| 36 | ARAF | 1.21414203 |
| 37 | STK38 | 1.19732910 |
| 38 | PRKCG | 1.19037900 |
| 39 | PHKG1 | 1.18576198 |
| 40 | PHKG2 | 1.18576198 |
| 41 | PRPF4B | 1.18223159 |
| 42 | EPHB2 | 1.15064491 |
| 43 | TYRO3 | 1.13629625 |
| 44 | NUAK1 | 1.11929509 |
| 45 | BCKDK | 1.08686292 |
| 46 | LATS1 | 1.08098325 |
| 47 | FES | 1.07021444 |
| 48 | CDK19 | 1.01669178 |
| 49 | RIPK4 | 0.99111679 |
| 50 | INSRR | 0.98785519 |
| 51 | CDK18 | 0.94326215 |
| 52 | CAMK2A | 0.94215499 |
| 53 | MAP3K2 | 0.93592006 |
| 54 | CDK15 | 0.91974918 |
| 55 | SGK223 | 0.91167078 |
| 56 | SGK494 | 0.91167078 |
| 57 | CDK14 | 0.90986875 |
| 58 | BMPR1B | 0.90454653 |
| 59 | CSNK1G2 | 0.85802166 |
| 60 | PAK3 | 0.82246717 |
| 61 | STK11 | 0.80469196 |
| 62 | PKN1 | 0.80201489 |
| 63 | CDK11A | 0.79654261 |
| 64 | CAMKK2 | 0.78956792 |
| 65 | DYRK1B | 0.77030496 |
| 66 | CAMK1 | 0.76941258 |
| 67 | WNK3 | 0.76189721 |
| 68 | SGK2 | 0.75680014 |
| 69 | PRKCH | 0.73628112 |
| 70 | DYRK1A | 0.73246398 |
| 71 | RET | 0.72589002 |
| 72 | TAOK1 | 0.72201543 |
| 73 | MAP3K13 | 0.71957318 |
| 74 | MARK2 | 0.71644292 |
| 75 | CAMK2B | 0.71570058 |
| 76 | ALK | 0.70025449 |
| 77 | LMTK2 | 0.68093622 |
| 78 | GRK1 | 0.66736930 |
| 79 | ZAK | 0.65826379 |
| 80 | STK38L | 0.65353201 |
| 81 | SGK1 | 0.63194323 |
| 82 | CDC42BPA | 0.62009543 |
| 83 | MKNK1 | 0.60511142 |
| 84 | TIE1 | 0.60231731 |
| 85 | RAF1 | 0.60160579 |
| 86 | ERBB3 | 0.59887622 |
| 87 | FRK | 0.58431795 |
| 88 | SGK3 | 0.58352099 |
| 89 | SCYL2 | 0.57434770 |
| 90 | RPS6KA4 | 0.57180256 |
| 91 | AKT3 | 0.55363356 |
| 92 | ADRBK2 | 0.55160705 |
| 93 | OBSCN | 0.54799234 |
| 94 | OXSR1 | 0.54116460 |
| 95 | VRK1 | 0.53453229 |
| 96 | FER | 0.53138042 |
| 97 | BCR | 0.52937489 |
| 98 | CAMK1G | 0.52475435 |
| 99 | PTK2B | 0.52444382 |
| 100 | LIMK1 | 0.51439782 |
| 101 | MKNK2 | 0.49858366 |
| 102 | RPS6KA3 | 0.49428567 |
| 103 | PRKCZ | 0.49330361 |
| 104 | PRKCE | 0.48657093 |
| 105 | CSNK1A1 | 0.48541090 |
| 106 | PRKAA1 | 0.47214695 |
| 107 | TNK2 | 0.47042596 |
| 108 | TSSK6 | 0.46904754 |
| 109 | RPS6KA2 | 0.46599405 |
| 110 | PINK1 | 0.45805304 |
| 111 | MAPK10 | 0.45621202 |
| 112 | CSNK1D | 0.45243669 |
| 113 | NME1 | 0.45126852 |
| 114 | CSNK1G3 | 0.44539449 |
| 115 | PRKACA | 0.42872281 |
| 116 | NEK1 | 0.41648320 |
| 117 | CAMK4 | 0.41294333 |
| 118 | CCNB1 | 0.41165560 |
| 119 | PRKACB | 0.40485254 |
| 120 | FYN | 0.40276437 |
| 121 | CDK3 | 0.39393992 |
| 122 | CAMK2D | 0.38588742 |
| 123 | ADRBK1 | 0.37375790 |
| 124 | BRAF | 0.37317330 |
| 125 | BRSK1 | 0.37130183 |
| 126 | DYRK2 | 0.36963627 |
| 127 | ERBB2 | 0.36811088 |
| 128 | DDR2 | 0.36777140 |
| 129 | BRD4 | 0.36585807 |
| 130 | PRKDC | 0.36482221 |
| 131 | MAP3K1 | 0.36088501 |
| 132 | PRKG1 | 0.35534646 |
| 133 | CAMK2G | 0.35512992 |
| 134 | SIK3 | 0.35208416 |
| 135 | MAP2K1 | 0.34877099 |
| 136 | PRKCB | 0.34602627 |
| 137 | FGFR2 | 0.34316637 |
| 138 | CSNK1E | 0.34043863 |
| 139 | ROCK2 | 0.33985465 |
| 140 | ERBB4 | 0.33277249 |
| 141 | PLK3 | 0.31029652 |
| 142 | MAPK15 | 0.30687659 |
| 143 | RPS6KA5 | 0.30420140 |
| 144 | MAPK9 | 0.29170541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.06348945 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.45522383 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.90939785 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.76032301 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72392649 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68542501 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.59237016 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54616673 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54153227 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40344565 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.35617558 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.24284029 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.19009867 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.00943860 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92087422 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90709818 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.88283313 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.81869438 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.81436741 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.80459362 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76971234 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.76122685 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75776117 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74297729 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71742828 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69518512 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.67223700 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66265282 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60019288 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59499221 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56952710 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53819574 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49369296 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.47911331 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42551313 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41754904 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.37732828 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34715435 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.31353007 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26228387 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22042173 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20480309 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20321927 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18959401 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15219625 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.15026277 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.13956852 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12658542 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 1.10735656 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.07845476 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05990318 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05531411 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04728174 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02286718 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.01920827 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00729835 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00493162 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98901122 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98723727 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98414894 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93878793 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92252607 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89786685 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.89746912 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87126283 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84926168 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83916281 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80481865 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79904875 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79861934 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78110538 |
| 72 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77856278 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77711256 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.77344917 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77205341 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73449369 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72239573 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70826967 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70739252 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70607109 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70399430 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.67635891 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67312393 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65966045 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65924826 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65522770 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65326998 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64474125 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63715252 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62988692 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.61521878 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60778910 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60236018 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60111988 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58408430 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58163029 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58065566 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57758028 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57239921 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56728677 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56704316 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55560139 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55466041 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54427555 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54346266 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54212309 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53929757 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53755411 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51743653 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50679886 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49928908 |
| 112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49910780 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49778980 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49629463 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48905737 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47703506 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47200146 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45186838 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.44453508 |
| 120 | Base excision repair_Homo sapiens_hsa03410 | 0.43683908 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43596350 |
| 122 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43394069 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43327447 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42888473 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.42441862 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42107013 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40566478 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39825982 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38872749 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38100434 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37816395 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37569324 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36112907 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36004064 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35834036 |
| 136 | Bile secretion_Homo sapiens_hsa04976 | 0.35703496 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35514564 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34550886 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34547866 |
| 140 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34343213 |
| 141 | Spliceosome_Homo sapiens_hsa03040 | 0.33990429 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33921810 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32690344 |
| 144 | Tight junction_Homo sapiens_hsa04530 | 0.28084164 |
| 145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26424688 |

